• +605 249 0500
  • enquiries@qiup.edu.my

Prof. Dr. Aman Shah B. Abdul Majid

Professor & Head of Pharmacology,
Faculty of Medicine

Qualifications:

  • B.Sc. (Pharmac,Otago)
  • PG.Dip.Pharm(Otago)
  • M.B.Ch.B (Sheffield)
  • D.Phil (Oxon)

Teaching and Research Experience:

Dr. Aman has been actively involved in teaching at both postgraduate and undergraduate level throughout his academic and clinical career since 2005. He currently supervises 9 PhD students (3 graduated) and graduated 4 MSc (Research) students.

  • Teaching Experience: 10 Years
  • Research Experience: 10 Years

Major Research Interest

Dr. Aman currently heads and coordinates several ongoing international regulatory clinical trials evaluating the safety and efficacy of standardized botanical drugs as adjuvant therpay for cancer management.

His main pre-clinical research interest is in the development and testing of novel therapeutic agents derived from natural products for the treatment of cancer, age related neurodegenerative diseases such as dementia, glaucoma and age related macula degeneration. His research at Oxford University led by the eminent Professor of Ocular Neuroscience, Neville N. Osborne in collaboration with CTG Pharma, Italy, was the world’s first to evaluate the hydrogen sulphide releasing (ACS) derivatives in a model of ischaemia induced retinal neuron degeneration. This novel scientific data was recently published in numerous high impact peer reviewed international journals.

In collaboration with several private R&D and pharmaceutical companies, he has helped to develop a robust research platform in the study and development of natural and synthetic compounds which can potentially modulate molecular pathways involved in neurodegeneration, inflammation, angiogenesis and carcinogenesis. To date he has helped secure almost 50 million ringgit of research grants for which he acts as a principal as well as a co-researcher. He has over 30 international publications and has won numerous prestigious academic research and innovation awards.

Administrative Appointments / Committee Involvements
  • Member of The Join Committee on Issues Related to Biosafety/Animal Care, Use & Ethics/Human Research Ethics, Quest International University
  • Assoc. Editor: Cancer Therapeutics Letters, Singapore
  • Editor: Austin Journal of Pharmaceutical and Analytical Chemistry, USA
  • Editor (Aging/Neurosciences): WebMed Central, United Kingdom
  • Reviewer: PLOS One (inc. several other ISI journals)
  • Editor: Aperito Journal of Ophthalmology, California, USA
Professional Involvement

Medical Consultant under the Ministry of Agriculture’s (Entry Point Project 1 High Value Herbs) to NKEA pharmaceutical companies engaging in herbal drug development from pre-clinical to clinical research:

  1. NatureCeuticals Sdn. Bhd.
  2. Orchid Life Sdn. Bhd.
  3. Deputy Chairman: Penang Cancer and Angiogenesis Research Society
  4. Honorary Medical Consultant – LiveYoung Sdn. Bhd.
  5. Member of New Zealand Cancer Society, Otago, Dunedin
  6. Assoc. Member of The Royal College of Physicians Edinbrugh
  7. Assoc. Member of The Royal College of Physcians, London
  8. Fellow of the Royal Society of Medicine ,London,UK
Selected Publications
 
Scroll to Top